{"product_id":"cleveland-clinic-nephrology-update-2026","title":"Cleveland Clinic Nephrology Update 2026","description":"\u003cdiv class=\"row\"\u003e\r\n\u003cdiv class=\"columns small-12 medium-12 large-12 sidebar-full\"\u003e\r\n\u003ch1 class=\"product_title entry-title\"\u003eCleveland Clinic Nephrology Update 2026\u003c\/h1\u003e\r\n\u003cstrong\u003e+ Target Audience: Nephrologists, Cardiologists, Critical Care Physicians, Oncologists, and Palliative Medicine Specialists\u003c\/strong\u003e\r\n\r\n\u003cstrong\u003e+ Information:\u003c\/strong\u003e\r\n\u003cdiv class=\"mb-2\"\u003e\r\n\u003cp data-path-to-node=\"0\"\u003eCleveland Clinic Nephrology Update 2026 is designed to provide a comprehensive review of the most up-to-date scientific data and analyze its implications for clinical practice. The program focuses on recent and emerging topics that directly impact day-to-day patient care. Led by expert faculty, the course addresses diagnostic and management strategies for patients with various kidney diseases, covering areas such as hypertension, cardio-kidney-metabolic syndrome, cystic kidney diseases, glomerular diseases, and vasculitis.\u003c\/p\u003e\r\n\u003cp data-path-to-node=\"1\"\u003e\u003cb data-path-to-node=\"1\" data-index-in-node=\"0\"\u003eLearning Objectives\u003c\/b\u003e\u003c\/p\u003e\r\n\u003cp data-path-to-node=\"1\"\u003eUpon completion of this activity, participants will be able to:\u003c\/p\u003e\r\n\r\n\u003cul data-path-to-node=\"2\"\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"2,0,0\"\u003eDescribe advances in the management of ADPKD and other cystic kidney diseases and review their impact on clinical practice.\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"2,1,0\"\u003eProvide an update on the pathogenesis and treatment of various glomerular diseases including IgA nephropathy, anti-GBM disease, ANCA-associated glomerulonephritis, lupus nephritis, thrombotic microangiopathy, and APOL1 nephropathy.\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"2,2,0\"\u003eSummarize the safety and efficacy of newer therapies for hypertension, including renal denervation, aldosterone synthase inhibitors, endothelin receptor agonists, and hepatic angiotensinogen silencing RNA, and describe their use in clinical practice, especially for resistant hypertension.\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"2,3,0\"\u003eEvaluate the latest evidence-based treatment strategies for hepato-renal and cardio-renal syndromes.\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"2,4,0\"\u003eHighlight updated approaches to managing kidney-related complications in cancer patients, including the nephrotoxic effects of immune checkp\u003cspan class=\"citation-1952 citation-1953 citation-end-1953\"\u003eoint inhibitors and targeted cancer therapeutics.\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp data-path-to-node=\"3\"\u003e\u003cb data-path-to-node=\"3\" data-index-in-node=\"0\"\u003e\u003cspan class=\"citation-1950 citation-1951 citation-end-1951\"\u003eTarget Audience\u003c\/span\u003e\u003c\/b\u003e\u003c\/p\u003e\r\n\r\n\u003cul\u003e\r\n \t\u003cli data-path-to-node=\"3\"\u003e\n\u003cspan class=\"citation-1948 citation-1949\"\u003eThis activity is designed for nephrologists, cardiologists, intensive care specialists, internists, nurses, nurse practitioners, physician assistants, an\u003c\/span\u003e\u003cspan class=\"citation-1944 citation-1945 citation-1946 citation-1947 citation-1948 citation-1949 citation-end-1949\"\u003ed other practicing health care professionals who desire an update on recent advancements in chronic kidney disea\u003c\/span\u003e\u003cspan class=\"citation-1944 citation-1945 citation-1946 citation-1947 citation-end-1947\"\u003ese management and treatment strategies.\u003c\/span\u003e\n\u003c\/li\u003e\r\n \t\u003cli data-path-to-node=\"3\"\u003e\u003cspan class=\"citation-1944 citation-1945 citation-1946 citation-1947 citation-end-1947\"\u003eBest for Nephrologists, Cardiologists, Critical Care Physicians, Oncologists, and Palliative Medicine Specialists.\u003c\/span\u003e\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp data-path-to-node=\"4\"\u003e\u003cb data-path-to-node=\"4\" data-index-in-node=\"0\"\u003e\u003cspan class=\"citation-1940 citation-1941 citation-end-1941\"\u003eTopics\u003c\/span\u003e\u003c\/b\u003e\u003c\/p\u003e\r\n\r\n\u003cul data-path-to-node=\"5\"\u003e\r\n \t\u003cli\u003e\r\n\u003col start=\"1\" data-path-to-node=\"5,0,0\"\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"5,0,0,0,0\"\u003e\u003cspan class=\"citation-1938 citation-1939 citation-end-1939\"\u003eMineral Bone Disease in CKD\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ol\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003col start=\"2\" data-path-to-node=\"5,1,0\"\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"5,1,0,0,0\"\u003e\u003cspan class=\"citation-1936 citation-1937 citation-end-1937\"\u003eMetabolic Acidosis in CKD\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ol\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003col start=\"3\" data-path-to-node=\"5,2,0\"\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"5,2,0,0,0\"\u003e\u003cspan class=\"citation-1934 citation-1935 citation-end-1935\"\u003eSaving Kidneys, Hearts, and Lives_ Understanding Cardio\u003c\/span\u003evascular-Kidney-Metabolic Syndrome\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ol\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003col start=\"4\" data-path-to-node=\"5,3,0\"\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"5,3,0,0,0\"\u003eHyperkalemia and RAAS Inhi\u003cspan class=\"citation-1933 citation-end-1933\"\u003ebitors_ Saving Kidneys, Hearts, and Lives\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ol\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003col start=\"5\" data-path-to-node=\"5,4,0\"\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"5,4,0,0,0\"\u003e\u003cspan class=\"citation-1932 citation-end-1932\"\u003eGLP-RA and the Kidneys_ a Nephrologist Perspective\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ol\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003col start=\"6\" data-path-to-node=\"5,5,0\"\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"5,5,0,0,0\"\u003e\u003cspan class=\"citation-1931 citation-end-1931\"\u003eCardiovascular Risk Reduction and Hyperlipidemia Management in CKD\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ol\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003col start=\"7\" data-path-to-node=\"5,6,0\"\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"5,6,0,0,0\"\u003e\u003cspan class=\"citation-1930 citation-end-1930\"\u003eADPKD Update\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ol\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003col start=\"8\" data-path-to-node=\"5,7,0\"\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"5,7,0,0,0\"\u003e\u003cspan class=\"citation-1929 citation-end-1929\"\u003eNon-ADPKD Cystic Kidney\u003c\/span\u003e Disease Cases\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ol\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003col start=\"9\" data-path-to-node=\"5,8,0\"\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"5,8,0,0,0\"\u003eCase Discussions\u003cspan class=\"citation-1926 citation-1927 citation-1928 citation-end-1928\"\u003e in ADPKD\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ol\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003col start=\"10\" data-path-to-node=\"5,9,0\"\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"5,9,0,0,0\"\u003e\u003cspan class=\"citation-1923 citation-1924 citation-1925 citation-end-1925\"\u003eJournal Club_1\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ol\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003col start=\"11\" data-path-to-node=\"5,10,0\"\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"5,10,0,0,0\"\u003e\u003cspan class=\"citation-1920 citation-1921 citation-1922 citation-end-1922\"\u003eJournal Club_2\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ol\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003col start=\"11\" data-path-to-node=\"5,11,0\"\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"5,11,0,0,0\"\u003e\u003cspan class=\"citation-1917 citation-1918 citation-1919 citation-end-1919\"\u003eAPOL1 Nephropathy\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ol\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003col start=\"12\" data-path-to-node=\"5,12,0\"\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"5,12,0,0,0\"\u003e\u003cspan class=\"citation-1914 citation-1915 citation-1916 citation-end-1916\"\u003ePrecision Medicine in Glomerular Diseases _ Neptune Match\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ol\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003col start=\"13\" data-path-to-node=\"5,13,0\"\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"5,13,0,0,0\"\u003e\u003cspan class=\"citation-1911 citation-1912 citation-1913 citation-end-1913\"\u003eUpdate on ANCA Disease_ Reducing the Steroid Burden\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ol\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003col start=\"14\" data-path-to-node=\"5,14,0\"\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"5,14,0,0,0\"\u003e\u003cspan class=\"citation-1908 citation-1909 citation-1910 citation-end-1910\"\u003eIgA Neph\u003c\/span\u003e\u003cspan class=\"citation-1908 citation-end-1908\"\u003eropathy_ Update on Pathogenesis and Treatment\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ol\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003col start=\"15\" data-path-to-node=\"5,15,0\"\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"5,15,0,0,0\"\u003e\u003cspan class=\"citation-1907 citation-end-1907\"\u003eComplement \u003c\/span\u003eAcross Glomerular Diseases\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ol\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003col start=\"16\" data-path-to-node=\"5,16,0\"\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"5,16,0,0,0\"\u003eClinicopathologic Case Discussions\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ol\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003col start=\"17\" data-path-to-node=\"5,17,0\"\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"5,17,0,0,0\"\u003eIntroduction_ Kasperzak Talk\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ol\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003col start=\"18\" data-path-to-node=\"5,18,0\"\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"5,18,0,0,0\"\u003eKasperzak Talk Anti-GBM Disease_ A State of the Art Update\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ol\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003col start=\"19\" data-path-to-node=\"5,19,0\"\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"5,19,0,0,0\"\u003eFuture Directions in Lupus Nephritis Management\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ol\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003col start=\"20\" data-path-to-node=\"5,20,0\"\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"5,20,0,0,0\"\u003eSelect Cases from the CCF GN Clinic\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ol\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003col start=\"21\" data-path-to-node=\"5,21,0\"\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"5,21,0,0,0\"\u003eThrombotic Microangiopathy_ a-HUS and Beyond\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ol\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003col start=\"22\" data-path-to-node=\"5,22,0\"\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"5,22,0,0,0\"\u003eClinicopathologic Case Discussions\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ol\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003col start=\"23\" data-path-to-node=\"5,23,0\"\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"5,23,0,0,0\"\u003eHypertension Guidelines Update\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ol\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003col start=\"24\" data-path-to-node=\"5,24,0\"\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"5,24,0,0,0\"\u003eUpdate on Hyperaldosteronism\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ol\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003col start=\"25\" data-path-to-node=\"5,25,0\"\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"5,25,0,0,0\"\u003ePractical Approach to Resistant Hypertension\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ol\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003col start=\"26\" data-path-to-node=\"5,26,0\"\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"5,26,0,0,0\"\u003eMedical Therapy in Hypertension_ An Evolving Landscape\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ol\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003col start=\"27\" data-path-to-node=\"5,27,0\"\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"5,27,0,0,0\"\u003eUpdate on Renal Denervation\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ol\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003col start=\"28\" data-path-to-node=\"5,28,0\"\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"5,28,0,0,0\"\u003eInnovations in BP Measurement\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ol\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003col start=\"29\" data-path-to-node=\"5,29,0\"\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"5,29,0,0,0\"\u003eUpdates in Hepato-Renal Syndrome\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ol\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003col start=\"30\" data-path-to-node=\"5,30,0\"\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"5,30,0,0,0\"\u003eCardio-Renal Syndrome\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ol\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003col start=\"31\" data-path-to-node=\"5,31,0\"\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"5,31,0,0,0\"\u003eAKI in Cancer\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ol\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003col start=\"32\" data-path-to-node=\"5,32,0\"\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"5,32,0,0,0\"\u003eAKI in the ICU\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ol\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003col start=\"33\" data-path-to-node=\"5,33,0\"\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"5,33,0,0,0\"\u003ePalliative Medicine Workshop_1\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ol\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003col start=\"33\" data-path-to-node=\"5,34,0\"\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"5,34,0,0,0\"\u003ePalliative Medicine Workshop_2\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ol\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"5,35,0\"\u003eSession I_ Cardiovascular Kidney Metabolic Syndrome, Part I\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"5,36,0\"\u003eSession II_ Cardiovascular Kidney Metabolic Syndrome, Part II\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"5,37,0\"\u003eSession III_ Cystic Kidney Diseases\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"5,38,0\"\u003eSession IV_ Journal Club\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"5,39,0\"\u003eSession V_ Glomerular Disease Update, Part I\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"5,40,0\"\u003eSession VI_ Glomerular Disease Update, Part II\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"5,41,0\"\u003eSession VII_ Glomerular Disease Update, Part III\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"5,42,0\"\u003eSession VIII_ Glomerular Disease Update, Part IV\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"5,43,0\"\u003eSession IX_ Hypertension Updates, Part I\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"5,44,0\"\u003eSession X_ Hypertension Updates, Part II\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"5,45,0\"\u003eSession XI_ AKI in Special Populations, Part I\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"5,46,0\"\u003eSession XII_ AKI in Special Populations, Part II\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e","brand":"Meducourse","offers":[{"title":"Default Title","offer_id":43163710128226,"sku":"MED-AMB09655","price":50.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/Cleveland-Clinic-Nephrology-Update-2026.jpg?v=1785419490","url":"https:\/\/meducourse.com\/products\/cleveland-clinic-nephrology-update-2026","provider":"Meducourse","version":"1.0","type":"link"}